Moreover, there is a growing body of evidence supporting the relationship between molecular changes in the glutamatergic system and the neurodegenerative processes triggered by Aβ in AD and other neurodegenerative diseases [19], even more since it was reported that Aβ interacts with mGluR5 [20]. Here, GRM5 is linked to Alzheimer disease.